Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Processa Pharmaceuticals, Inc.

NASDAQ: PCSA · Life Sciences · 5 alerts · CIK 1533743

Share price
$1.72Close, Nov 16
Market cap
$4.81M
Shares outstanding
2.8MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Processa Pharmaceuticals, Inc. filings on SEC EDGAR ↗

5:11 PM ET 10-Q
Financial Results

Processa Pharmaceuticals Q3 2026 Results: Net Loss of $183M, Loss Widens

Processa Pharmaceuticals reported a significant net loss of $189.8 million for the nine months ended September 30, 2026, primarily driven by a $178.0 million charge for acquired in-process research and development following the acquisition of Vidya Therapeutics. The company significantly strengthened its liquidity position during the period, ending with $180.2 million in cash and cash equivalents following a $200.0 million private placement financing.

Key figure
Net loss $183M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.